ON DEMAND WEBINAR
Duration: 1 hour​

Our expert panel will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including:

• Histopathology as a treatment target in IBD: Aspiration or Reality?
• Measuring histopathology in IBD trials
• Histopathology as a treatment target in NASH trials
• Measuring histopathology in NASH trials

SPEAKERS

David Rubin, MD
Chief, Section of Gastroenterology, Hepatology, and Nutrition
University of Chicago, IL

Rish Pai, MD, PhD
Histopathologist
Mayo Clinic, AZ

Stephen Harrison, MD
Hepatologist and Clinical Trialist
San Antonio, TX

Mark Valasek, MD
Associate Professor, Pathology
UCSD, CA